Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Nat Commun ; 11(1): 5240, 2020 10 16.
Article in English | MEDLINE | ID: mdl-33067457

ABSTRACT

Spoken language, both perception and production, is thought to be facilitated by an ensemble of predictive mechanisms. We obtain intracranial recordings in 37 patients using depth probes implanted along the anteroposterior extent of the supratemporal plane during rhythm listening, speech perception, and speech production. These reveal two predictive mechanisms in early auditory cortex with distinct anatomical and functional characteristics. The first, localized to bilateral Heschl's gyri and indexed by low-frequency phase, predicts the timing of acoustic events. The second, localized to planum temporale only in language-dominant cortex and indexed by high-gamma power, shows a transient response to acoustic stimuli that is uniquely suppressed during speech production. Chronometric stimulation of Heschl's gyrus selectively disrupts speech perception, while stimulation of planum temporale selectively disrupts speech production. This work illuminates the fundamental acoustic infrastructure-both architecture and function-for spoken language, grounding cognitive models of speech perception and production in human neurobiology.


Subject(s)
Auditory Cortex/physiopathology , Epilepsy/physiopathology , Acoustic Stimulation , Adult , Auditory Cortex/diagnostic imaging , Brain Mapping , Epilepsy/diagnostic imaging , Epilepsy/psychology , Female , Humans , Language , Magnetic Resonance Imaging , Male , Speech , Speech Perception , Young Adult
2.
Clin Endocrinol (Oxf) ; 80(1): 41-6, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23682759

ABSTRACT

OBJECTIVES: Vitamin D deficiency (VDD) is a global problem. Not all patients with VDD have clinical manifestations or secondary hyperparathyroidism. We studied the interaction between serum 25-hydroxy vitamin D (25OHD), parathormone (PTH) and bone mineral density (BMD) in Indian adolescents and adults. DESIGN: Population survey. PATIENTS: A total of 1829 adolescents and 1346 adults aged 50 years and above were analysed in this study. MEASUREMENTS: Serum biochemistry, 25OHD, PTH and BMD were estimated. Subjects were grouped according to quartiles of serum PTH. VDD was defined as severe (25OHD ≤ 5 ng/ml), moderate (25OHD ≤ 10 ng/ml) and mild (25OHD ≤ 20 ng/ml) and secondary hyperparathyroidism (SHPT) when serum PTH levels >65 pg/ml. RESULTS: Only 30-40% of subjects with moderate and severe VDD, respectively, had SHPT. BMD decreased from Quartile 1 to Quartile 4 of PTH at all sites among adolescents and adults, with only a marginal decline in serum 25OHD levels between these quartiles. Further, within each PTH quartile, there was no difference in BMD according to categories of VDD. Analysing BMD in the different PTH quartiles, the PTH cut-offs beyond which BMD showed a significant decline, was 35 pg/ml in adolescents and 53 pg/ml in adults. CONCLUSIONS: Less than half of the subjects with VDD have SHPT. BMD levels start to decline at PTH values currently considered to be normal. These data suggest the need to redefine SHPT in different age groups keeping in mind the relationship between PTH and BMD. This may also influence the decision to supplement subjects with VDD.


Subject(s)
Bone Density/physiology , Parathyroid Hormone/blood , Vitamin D/analogs & derivatives , Adolescent , Child , Female , Humans , India , Male , Vitamin D/blood , Vitamin D Deficiency/blood
3.
Article in English | MEDLINE | ID: mdl-19163485

ABSTRACT

Overcoming the limitations of diffusional transport in conventional culture systems remains an open issue for successfully generating thick, compact and functional cardiac tissues. Previously, it was shown that perfusion systems enhance the yield and uniformity of cell seeding and cell survival in thick cardiac constructs. The aim of our study was to form highly functional cardiac constructs starting from spatially uniform, high density cell seeded constructs. Disk-shaped elastomeric poly(glycerol sebacate) scaffolds were seeded with neonatal rat cardiomyocytes and cultured for eight days with direct perfusion of culture medium or statically in a six-well plate. In the perfusion experimental group, the integrity of some disks was well maintained, whereas in others a central hole was formed, resulting in ring-shaped constructs. This allowed us to also study the effects of construct geometry and of interstitial flow versus channel perfusion. The ring-shaped constructs appeared to have a denser and more uniform deposition of extracellular matrix. In response to electrical stimulation, the fractional area change of the ring-shaped constructs was 7.3 and 2.7 times higher than for disk-shaped tissues cultured in perfusion or statically, respectively. These findings suggest that a combination of many factors, including scaffold elasticity and geometry and the type of perfusion system applied, need to be considered in order to engineer a cardiac construct with high contractile activity.


Subject(s)
Muscle Contraction , Tissue Engineering/methods , Animals , Animals, Newborn , Bioreactors , Cells, Cultured , Decanoates/chemistry , Electric Stimulation Therapy/methods , Electrophysiology/methods , Extracellular Matrix/metabolism , Glycerol/analogs & derivatives , Glycerol/chemistry , Myocardium/metabolism , Myocardium/pathology , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Perfusion , Polymers/chemistry , Rats , Rats, Sprague-Dawley
4.
Transplant Proc ; 39(3): 750-2, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17445589

ABSTRACT

INTRODUCTION: Steroid-induced osteoporosis is a major problem after organ transplantation. There is considerable evidence that bisphosphonates are effective in decreasing osteoporosis. AIM: This prospective study was carried out to see the effects of bisphosphonates on bone mineral density (BMD) after successful renal transplantation. MATERIAL AND METHODS: Fifty consecutive patients of successful renal transplantation were randomized into two groups. Group A (n = 27) received 35 mg/wk of Alendronate for 6 months after transplantation. Group B (n = 23) did not receive Alendronate and served as a control. Both groups underwent a pretransplant baseline dual-energy X-ray absorptiometry (DEXA) scan of their hips and lumber spines. Both groups received oral calcium and vitamin D supplement. Both groups were matched for the regimen and dose of immunosuppressive drugs. BMD was measured at 3 months and 6 months after transplantation. RESULTS: Both groups showed a decline in BMD in early months posttransplantation. However, the 6-month DEXA scans showed a significant rise in BMD in group A as compared to group B. CONCLUSION: Bisphosphonates appear to have a beneficial effect on steroid-induced bone loss.


Subject(s)
Alendronate/adverse effects , Bone Density Conservation Agents/therapeutic use , Bone Density/drug effects , Kidney Transplantation/physiology , Absorptiometry, Photon , Adrenal Cortex Hormones/adverse effects , Femur/drug effects , Humans , Patient Selection , Prospective Studies , Spine/drug effects
5.
Thromb Res ; 104(2): 127-35, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11672756

ABSTRACT

It has been reported that platelets from some healthy donors did not respond to epinephrine (Epi). To identify the cause for the lack of response, we examined the alpha(2) adrenoceptor in the platelets and their signal transduction pathways. No differences in the genomic (-2076 to 1526 bp) and coding region of alpha(2A) adrenoceptor complementary DNA (cDNA) were found between the responders (R) and nonresponders (NR). No expression of alpha(2B) or alpha(2C) adrenoceptor was detected in platelets. When UK14,304 was used to induce platelet aggregation, similar effect to Epi was observed between R and NR, and any involvement of the alpha(1) and beta adrenoceptor was ruled out. Radioligand binding assay showed similar number of alpha(2) binding sites between the two groups (139+/-25/platelet vs. 145+/-37/platelets). However, platelets from NR showed a weaker response to adenosine diphosphate (ADP, 52.3+/-17.8% vs. 80.5+/-8.7% from R, P<.01). In the presence of P2Y(1) antagonist adenosine 3',5'-diphosphosulfate (A3P5PS), ADP failed to induce platelet aggregation in NR (7.8+/-4.7% vs. 64.7+/-11.2% in R, P<.01). Addition of SQ22,536 to inhibit adenylyl cyclase did not convert NR to R. These observations demonstrate that there is an impaired platelet responsiveness to ADP as well as to Epi in NR, due to a difference in downstream of the signal transduction pathway but independent of adenylyl cyclase inhibition.


Subject(s)
Adenosine Diphosphate/pharmacology , Adrenergic alpha-Agonists/pharmacology , Blood Platelets/drug effects , Epinephrine/pharmacology , Membrane Proteins , Base Sequence , Binding Sites , Cyclic AMP/metabolism , Dose-Response Relationship, Drug , Drug Resistance , Humans , Platelet Aggregation/drug effects , Purinergic P2 Receptor Antagonists , Receptors, Adrenergic, alpha-2/genetics , Receptors, Adrenergic, alpha-2/metabolism , Receptors, Adrenergic, alpha-2/physiology , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2Y12 , Signal Transduction
6.
J Ethnopharmacol ; 76(2): 139-43, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11390126

ABSTRACT

Insulin resistance has been implicated as a major contributor to the development of hyperglycemia in NIIDM patients. Herbal extracts of Momordica charantia (MC) and Eugenia jambolana (EJ) have been shown to reduce hyperglycemia in diabetic animal models and human patients. However, no work has been done so far to assess their effect on insulin resistance. This study was undertaken to study the effects of different doses (100,200 and 400 mg per day) of alcoholic and aqueous extracts of MC and EJ on the metabolic parameters (body weight and serum glucose, insulin and triglycerides levels) of fructose fed rats. Fructose feeding for 15 days increased serum glucose and insulin levels markedly and triglycerides levels marginally vs. control (75.46+/-2.41 vs. 55.59+/-2.89 mg/dl, 6.26+/-1.27 vs. 15.04+/-2.43 mg/dl and 50.93+/-3.30 vs.41.1+/-3.33 mg/dl, respectively). Treatment with 400 mg per day of aqueous extracts of MC and EJ for 15 days substantially prevented hyperglycemia and hyperinsulinemia induced by a diet high in fructose (63.52+/-2.9 and 66.46+/-2.2 vs. 75.46+/-2.4, respectively).


Subject(s)
Fructose/pharmacology , Hyperglycemia/prevention & control , Hyperinsulinism/prevention & control , Hypoglycemic Agents/therapeutic use , N-Glycosyl Hydrolases , Plant Extracts/therapeutic use , Plant Proteins/therapeutic use , Analysis of Variance , Animals , Blood Glucose/drug effects , Body Weight/drug effects , Dose-Response Relationship, Drug , Female , Insulin/blood , Insulin Resistance , Male , Rats , Ribosome Inactivating Proteins, Type 2 , Triglycerides/blood
7.
Lancet ; 340(8820): 633-6, 1992 Sep 12.
Article in English | MEDLINE | ID: mdl-1381035

ABSTRACT

Thyroid cells are exposed to complement attack in Graves' disease and Hashimoto's thyroiditis, but are resistant to killing by homologous complement. We have examined the effects of sublethal complement attack on thyroid cells in vitro. Extracellular reactive oxygen metabolites were produced and prostaglandin E2, interleukin-1 alpha, and interleukin-6 were released after complement attack. Cells pretreated with interferon-gamma and interleukin-1 alpha, which increase expression of CD59, were more resistant to these effects of complement. Conversely, blockade of CD59 with monoclonal antibody increased complement-mediated oxygen radical production and release of prostaglandin E2, interleukin-1 alpha, and interleukin-6. The antithyroid drugs methimazole and propylthiouracil abolished or reduced oxygen radical production by complement-attacked thyroid cells and reduced cytokine release. These results suggest that sublethal complement attack in autoimmune thyroid diseases exacerbates tissue injury by causing thyroid cells to release potent phlogistic mediators, although some degree of protection may be afforded in vivo by cytokine-mediated upregulation of CD59. Antithyroid drugs, concentrated within thyroid cells, will prevent the release of these inflammatory molecules, which may in turn explain the amelioration of thyroiditis and remission of Graves' disease after such treatment.


Subject(s)
Antigens, CD/immunology , Interferon-gamma/immunology , Interleukin-1/immunology , Interleukin-6/metabolism , Membrane Glycoproteins/immunology , Oxygen/metabolism , Prostaglandins E/metabolism , Thyroid Gland/immunology , CD59 Antigens , Complement Pathway, Classical/immunology , Drug Evaluation, Preclinical , Free Radicals , Humans , Interleukin-1/metabolism , Methimazole/pharmacology , Propylthiouracil/pharmacology , Thyroid Gland/drug effects , Thyroid Gland/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL